Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/annual-reviews/rank-l-and-rank-t-cells-bone-loss-and-mammalian-evolution-ZbfjSniwbx
References (131)
-
Yasuhiro Yamada, I. Kirillova, J. Peschon, N. Fausto (1997)
Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.Proceedings of the National Academy of Sciences of the United States of America, 94 4
-
B. Wong, D. Besser, N. Kim, J. Arron, M. Vologodskaia, M. Vologodskaia, H. Hanafusa, Yongwon Choi, Yongwon Choi (1999)
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.Molecular cell, 4 6
-
T. Burgess, Y. Qian, S. Kaufman, B. Ring, G. Van, Charles Capparelli, M. Kelley, H. Hsu, W. Boyle, C. Dunstan, Sylvia Hu, D. Lacey (1999)
The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature OsteoclastsThe Journal of Cell Biology, 145
-
E. Lagasse, I. Weissman (1997)
Enforced Expression of Bcl-2 in Monocytes Rescues Macrophages and Partially Reverses Osteopetrosis in op/op MiceCell, 89
-
R. Josien, B. Wong, Hong‐li Li, R. Steinman, Yongwon Choi (1999)
TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.Journal of immunology, 162 5
-
P. Togni, J. Goellner, N. Ruddle, P. Streeter, A. Fick, S. Mariathasan, Scott Smith, R. Carlson, L. Shornick, J. Strauss-Schoenberger (1994)
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.Science, 264 5159
-
Ji Li, I. Sarosi, Xiao-Qiang Yan, S. Morony, C. Capparelli, H. Tan, Susan McCabe, R. Elliott, S. Scully, Gwyneth Van, S. Kaufman, Shao Juan, Yu Sun, J. Tarpley, Laura Martin, Kathleen Christensen, J. Mccabe, P. Kostenuik, H. Hsu, F. Fletcher, C. Dunstan, D. Lacey, W. Boyle (2000)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.Proceedings of the National Academy of Sciences of the United States of America, 97 4
-
M. Alimzhanov, D. Kuprash, Marie Kosco-Vilbois, Arne Luz, R. Turetskaya, Alexander Tarakhovsky, Klaus Rajewsky, S. Nedospasov, Klaus Pfeffer (1997)
Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.Proceedings of the National Academy of Sciences of the United States of America, 94 17
-
G. Granger, S. Shacks, Terry Williams, W. Kolb (1969)
Lymphocyte in vitro Cytotoxicity: Specific Release of Lymphotoxin-like Materials from Tuberculin-sensitive Lymphoid CellsNature, 221
-
R. Josien, Hong‐li Li, E. Ingulli, S. Sarma, Brian R.Wong, M. Vologodskaia, R. Steinman, Yongwon Choi (2000)
Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in VivoThe Journal of Experimental Medicine, 191
-
Jin Wang, Lixin Zheng, A. Lobito, F. Chan, J. Dale, M. Sneller, Xue-biao Yao, J. Puck, S. Straus, M. Lenardo (1999)
Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type IICell, 98
-
A. Fütterer, K. Mink, A. Luz, M. Kosco-Vilbois, K. Pfeffer (1998)
The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues.Immunity, 9 1
-
Y. Abu-Amer (2001)
IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κBJournal of Clinical Investigation, 107
-
A. Bendele, J. McComb, T. Gould, T. Mcabee, G. Sennello, E. Chlipala, Michael Guy (1999)
Animal Models of Arthritis: Relevance to Human DiseaseToxicologic Pathology, 27
-
Vera Fantl, Paul Edwards, Jennifer Steel, B. Vonderhaar, Clive Dickson (1999)
Impaired mammary gland development in Cyl-1(-/-) mice during pregnancy and lactation is epithelial cell autonomous.Developmental biology, 212 1
-
Z. Lee, K. Kwack, K. Kim, Sang Lee, Hong-Hee Kim (2000)
Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.Molecular pharmacology, 58 6
-
N. Kayagaki, N. Yamaguchi, Masafumi Nakayama, A. Kawasaki, H. Akiba, K. Okumura, H. Yagita (1999)
Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.Journal of immunology, 162 5
-
L. Jørgensen, T. Engstad, B. Jacobsen (2001)
Bone Mineral Density in Acute Stroke Patients: Low Bone Mineral Density May Predict First Stroke in WomenStroke: Journal of the American Heart Association, 32
-
M. Martínez-Lorenzo, A. Anel, S. Gamen, Inmaculada Monleón, P. Lasierra, L. Larrad, A. Piñeiro, M. Alava, Javier Naval (1999)
Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.Journal of immunology, 163 3
-
A. Strasser, K. Newton (1999)
FADD/MORT1, a signal transducer that can promote cell death or cell growth.The international journal of biochemistry & cell biology, 31 5
-
J. Fata, Y. Kong, Ji Li, Takehiko Sasaki, J. Irie-Sasaki, R. Moorehead, R. Elliott, S. Scully, E. Voura, D. Lacey, W. Boyle, R. Khokha, J. Penninger (2000)
The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland DevelopmentCell, 103
-
S. Morony, C. Capparelli, Richard Lee, G. Shimamoto, T. Boone, D. Lacey, C. Dunstan (1999)
A Chimeric Form of Osteoprotegerin Inhibits Hypercalcemia and Bone Resorption Induced by IL‐1β, TNF‐α, PTH, PTHrP, and 1,25(OH)2D3Journal of Bone and Mineral Research, 14
-
H. Hsu, D. Lacey, C. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. Tan, G. Elliott, M. Kelley, I. Sarosi, L. Wang, X. Xia, R. Elliott, L. Chiu, Tabitha Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M. Bass, W. Boyle (1999)
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.Proceedings of the National Academy of Sciences of the United States of America, 96 7
-
A. Hughes, S. Ralston, J. Marken, C. Bell, H. Macpherson, R. Wallace, W. Hul, M. Whyte, Kyoshi Nakatsuka, L. Hovy, Dirk Anderson (2000)
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysisNature Genetics, 24
-
M. Matsumoto, T. Sudo, Tamio Saito, Hiroyuki Osada, M. Tsujimoto (2000)
Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)*The Journal of Biological Chemistry, 275
-
Robert Coleman (1998)
How can we improve the treatment of bone metastases further?Current opinion in oncology, 10 Suppl 1
-
V. Kouskoff, A. Korganow, V. Duchatelle, C. Degott, C. Benoist, D. Mathis (1996)
Organ-Specific Disease Provoked by Systemic AutoimmunityCell, 87
-
V. Iotsova, J. Caamaño, J. Loy, Yi Yang, A. Lewin, R. Bravo (1997)
Osteopetrosis in mice lacking NF-κB1 and NF-κB2Nature Medicine, 3
-
J. Banchereau, R. Steinman (1998)
Dendritic cells and the control of immunityNature, 392
-
M. Matsumoto, S. Mariathasan, M. Nahm, F. Baranyay, J. Peschon, D. Chaplin (1996)
Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal CentersScience, 271
-
N. Cross, L. Hillman, S. Allen, G. Krause, N. Vieira (1995)
Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study.The American journal of clinical nutrition, 61 3
-
G. Panayi, Jerry Lanchbury, G. Kingsley (1992)
The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis.Arthritis and rheumatism, 35 7
-
G. Atkins, S. Bouralexis, D. Haynes*, S. Graves, S. Geary, A. Evdokiou, A. Zannettino, S. Hay, D. Findlay (2001)
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.Bone, 28 4
-
M. Kanematsu, Takuya Sato, H. Takai, Ken Watanabe, K. Ikeda, Y. Yamada (2000)
Prostaglandin E2 Induces Expression of Receptor Activator of Nuclear Factor–κB Ligand/Osteoprotegrin Ligand on Pre‐B Cells: Implications for Accelerated Osteoclastogenesis in Estrogen DeficiencyJournal of Bone and Mineral Research, 15
-
Y. Azuma, K. Kaji, Rei Katogi, S. Takeshita, A. Kudo (2000)
Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts*The Journal of Biological Chemistry, 275
-
E. Carswell, L. Old, R. Kassel, S. Green, N. Fiore, B. Williamson (1975)
An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences of the United States of America, 72 9
-
B. Darnay, V. Haridas, Jian Ni, P. Moore, B. Aggarwal (1998)
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.The Journal of biological chemistry, 273 32
-
W. Thomas, P. Hersey (1998)
TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells.Journal of immunology, 161 5
-
Paul Rennert, Jeffrey Browning, P. Hochman (1997)
Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.International immunology, 9 11
-
L. Galibert, Mark Tometsko, Dirk Anderson, D. Cosman, W. Dougall (1998)
The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily*The Journal of Biological Chemistry, 273
-
P. Koni, R. Sacca, P. Lawton, J. Browning, N. Ruddle, R. Flavell (1997)
Distinct Roles in Lymphoid Organogenesis for Lymphotoxins α and β Revealed in Lymphotoxin β–Deficient MiceImmunity, 6
-
A. Stellon, A. Davies, J. Compston, R. Williams (1985)
Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy.Gastroenterology, 89 5
-
A. Bendixen, N. Shevde, K. Dienger, T. Willson, C. Funk, J. Pike (2001)
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1Proceedings of the National Academy of Sciences of the United States of America, 98
-
Richard Williams, M. Feldmann, R. Maini (2000)
Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor αAnnals of the Rheumatic Diseases, 59
-
N. Vidal, H. Brändström, K. Jonsson, C. Ohlsson (1998)
Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids.The Journal of endocrinology, 159 1
-
H. Brändström, K. Jonsson, Claes Ohlsson, O. Vidal, Sverker Ljunghall, Ö. Ljunggren (1998)
Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells.Biochemical and biophysical research communications, 247 2
-
M. Feldmann, F. Brennan, R. Maini (1996)
Role of cytokines in rheumatoid arthritis.Annual review of immunology, 14
-
F. Ross (2000)
RANKing the importance of measles virus in Paget's disease.The Journal of clinical investigation, 105 5
-
R. Myllykangas-Luosujärvi, K. Aho, H. Kautiainen, M. Hakala (2000)
Reduced incidence of alcohol related deaths in subjects with rheumatoid arthritisAnnals of the Rheumatic Diseases, 59
-
N. Kobayashi, Y. Kadono, A. Naito, Kunihiro Matsumoto, Tadashi Yamamoto, Sakae Tanaka, J. Inoue (2001)
Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesisThe EMBO Journal, 20
-
B. Wong, R. Josien, Soo Lee, M. Vologodskaia, R. Steinman, Yongwon Choi (1998)
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor*The Journal of Biological Chemistry, 273
-
H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, Akihiro Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, T. Suda (1998)
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.Proceedings of the National Academy of Sciences of the United States of America, 95 7
-
J. Conway, J. Wakefield, H. Roger, Brown, B. Marron, L. Sekut, Stephen impson, Andrew McElroy, J. Menius, John Jeffreys, R. Clark, M. Gerard, McGeehan, M. Kevin, Connollyll (1995)
Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitorThe Journal of Experimental Medicine, 182
-
K. Fye (1999)
New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs.Postgraduate medicine, 106 4
-
G. Karsenty (1999)
The genetic transformation of bone biology.Genes & development, 13 23
-
T. Nakashima, Y. Kobayashi, S. Yamasaki, A. Kawakami, K. Eguchi, H. Sasaki, H. Sakai (2000)
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.Biochemical and biophysical research communications, 275 3
-
Cyrus Cooper, L.Joseph Melton (1992)
Epidemiology of osteoporosisTrends in Endocrinology & Metabolism, 3
-
Y. Yokota, A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, P. Gruss (1999)
Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2Nature, 397
-
P. Rennert, D. James, F. Mackay, J. Browning, P. Hochman (1998)
Lymph Node Genesis Is Induced by Signaling through the Lymphotoxin β ReceptorImmunity, 9
-
M. Roy, T. Waldschmidt, A. Aruffo, J. Ledbetter, R. Noelle (1993)
The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.Journal of immunology, 151 5
-
A. Pettit, H. Ji, D. Stechow, R. Mueller, Y. Choi, S. Goldring, C. Benoist, E. Gravallese (2001)
TRANCE/RANKL knockout mice are protected from bone erosion in the K/BxN serum transfer model of arthritisArthritis & Rheumatism, 44
-
J. Emery, P. Mcdonnell, M. Burke, K. Deen, S. Lyn, C. Silverman, E. Dul, E. Appelbaum, C. Eichman, R. DiPrinzio, R. Dodds, I. James, Martin Rosenberg, John Lee, P. Young (1998)
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*The Journal of Biological Chemistry, 273
-
M. Saika, D. Inoue, S. Kido, Toshio Matsumoto (2001)
17β-Estradiol Stimulates Expression of Osteoprotegerin by a Mouse Stromal Cell Line, ST-2, via Estrogen Receptor-α.Endocrinology, 142 6
-
S. Morony, C. Capparelli, I. Sarosi, D. Lacey, C. Dunstan, P. Kostenuik (2001)
Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.Cancer research, 61 11
-
Dirk Anderson, E. Maraskovsky, William Billingsley, W. Dougall, Mark Tometsko, E. Roux, M. Teepe, R. Dubose, D. Cosman, L. Galibert (1997)
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell functionNature, 390
-
L. Lum, B. Wong, R. Josien, J. Becherer, H. Erdjument-Bromage, J. Schlöndorff, P. Tempst, Yongwon Choi, C. Blobel (1999)
Evidence for a Role of a Tumor Necrosis Factor-α (TNF-α)-converting Enzyme-like Protease in Shedding of TRANCE, a TNF Family Member Involved in Osteoclastogenesis and Dendritic Cell Survival*The Journal of Biological Chemistry, 274
-
G. Pereira, A. Zucker (1986)
Nutritional deficiencies in the neonate.Clinics in perinatology, 13 1
-
G. Roodman (1999)
Cell biology of the osteoclast.Experimental hematology, 27 8
-
J. Brandt, H. Haibel, Daniel Cornely, W. Golder, J. González, J. Reddig, W. Thriene, J. Sieper, Jürgen Braun (2000)
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab.Arthritis and rheumatism, 43 6
-
Y. Kong, U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, Ji Li, R. Elliott, Susan McCabe, Thomas Wong, G. Campagnuolo, E. Moran, E. Bogoch, G. Van, L. Nguyen, P. Ohashi, D. Lacey, E. Fish, W. Boyle, J. Penninger (1999)
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligandNature, 402
-
Manolis Pasparakis, Lena Alexopoulou, Matthias Grell, Klaus Pfizenmaier, Horst Bluethmann, G. Kollias (1997)
Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.Proceedings of the National Academy of Sciences of the United States of America, 94 12
-
C. Benoist, D. Mathis (2000)
A revival of the B cell paradigm for rheumatoid arthritis pathogenesis?Arthritis Research, 2
-
R. Locksley, N. Killeen, M. Lenardo (2001)
The TNF and TNF Receptor Superfamilies Integrating Mammalian BiologyCell, 104
-
B. Sauter, M. Albert, Loise Francisco, M. Larsson, Selin Somersan, N. Bhardwaj (2000)
Consequences of cell death: exposure to necrotic tumor cells -
Yan-hong Zhang, Antoinette Heulsmann, M. Tondravi, A. Mukherjee, Y. Abu-Amer (2001)
Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways*The Journal of Biological Chemistry, 276
-
T. Kawabe, T. Naka, Kanji Yoshida, Takashi Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, H. Kikutani (1994)
The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.Immunity, 1 3
-
J. Keffer, L. Probert, Haris Caziaris, S. Georgopoulos, E. Kaslaris, D. Kioussis, G. Kollias (1991)
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.The EMBO Journal, 10
-
J. Arron, M. Vologodskaia, B. Wong, M. Naramura, N. Kim, Hua Gu, Yongwon Choi (2001)
A Positive Regulatory Role for Cbl Family Proteins in Tumor Necrosis Factor-related Activation-induced Cytokine (TRANCE) and CD40L-mediated Akt Activation*The Journal of Biological Chemistry, 276
-
P. Honore, N. Luger, M. Sabino, M. Schwei, S. Rogers, D. Mach, Patrick O'keefe, M. Ramnaraine, D. Clohisy, P. Mantyh (2000)
Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cordNature Medicine, 6
-
Dongku Kim, R. Mebius, J. MacMicking, Steffen Jung, T. Cupedo, Yaneth Castellanos, Jaerang Rho, B. Wong, R. Josien, N. Kim, P. Rennert, Yongwon Choi (2000)
Regulation of Peripheral Lymph Node Genesis by the Tumor Necrosis Factor Family Member TranceThe Journal of Experimental Medicine, 192
-
W. Graninger, J. Smolen (2001)
One-year inhibition of tumor necrosis factor-alpha: a major success or a larger puzzle?Current opinion in rheumatology, 13 3
-
G. Robinson, A. Karpf, K. Kratochwil (2004)
Regulation of Mammary Gland Development by Tissue InteractionJournal of Mammary Gland Biology and Neoplasia, 4
-
A. Naito, S. Azuma, Sakae Tanaka, T. Miyazaki, S. Takaki, K. Takatsu, K. Nakao, Kenji Nakamura, M. Katsuki, Tadashi Yamamoto, Jun-ichiro Inoue (1999)
Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient miceGenes to Cells, 4
-
T. Yun, M. Tallquist, A. Aicher, K. Rafferty, A. Marshall, J. Moon, Maria Ewings, M. Mohaupt, S. Herring, E. Clark (2001)
Osteoprotegerin, a Crucial Regulator of Bone Metabolism, Also Regulates B Cell Development and Function1The Journal of Immunology, 166
-
C. Whitacre, S. Reingold, P. O'Looney, E. Blankenhorn, F. Brinley, E. Collier, P. Duquette, Howard Fox, B. Giesser, W. Gilmore, R. Lahita, J. Nelson, Carol Reiss, Peter Riskind, R. Voskuhl (1999)
A Gender Gap in AutoimmunityScience, 283
-
B. Wong, J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, Eftihia Cayani, F. Bartlett, W. Frankel, Soo Lee, Yongwon Choi (1997)
TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*The Journal of Biological Chemistry, 272
-
N. Kim, P. Odgren, Dongkoon Kim, S. Marks,, Yongwon Choi (2000)
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene.Proceedings of the National Academy of Sciences of the United States of America, 97 20
-
A. Mizuno, A. Murakami, N. Nakagawa, H. Yasuda, E. Tsuda, T. Morinaga, K. Higashio (1998)
Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis.Gene, 215 2
-
H. Boehmer, H. Fehling (1997)
Structure and function of the pre-T cell receptor.Annual review of immunology, 15
-
E. Ingulli, A. Mondino, A. Khoruts, M. Jenkins (1997)
In Vivo Detection of Dendritic Cell Antigen Presentation to CD4+ T CellsThe Journal of Experimental Medicine, 185
-
W. Dougall, M. Glaccum, K. Charrier, Kathy Rohrbach, K. Brasel, T. Smedt, E. Daro, Jeffery Smith, Mark Tometsko, C. Maliszewski, A. Armstrong, Victor Shen, S. Bain, D. Cosman, Dirk Anderson, P. Morrissey, J. Peschon, J. Schuh (1999)
RANK is essential for osteoclast and lymph node development.Genes & development, 13 18
-
N. Horwood, J. Elliott, T. Martin, M. Gillespie (2001)
IL-12 Alone and in Synergy with IL-18 Inhibits Osteoclast Formation In Vitro1The Journal of Immunology, 166
-
Hosung Min, S. Morony, I. Sarosi, C. Dunstan, C. Capparelli, S. Scully, G. Van, S. Kaufman, P. Kostenuik, D. Lacey, W. Boyle, W. Simonet (2000)
Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling OsteoclastogenesisThe Journal of Experimental Medicine, 192
-
B. Piepkorn, P. Kann, T. Forst, J. Andreas, A. Pfützner, J. Beyer (1997)
Bone Mineral Density and Bone Metabolism in Diabetes MellitusHormone and Metabolic Research, 29
-
J. Buyon (1998)
The effects of pregnancy on autoimmune diseasesJournal of Leukocyte Biology, 63
-
J. Pollard, L. Hennighausen (1994)
Colony stimulating factor 1 is required for mammary gland development during pregnancy.Proceedings of the National Academy of Sciences of the United States of America, 91 20
-
N. Bucay, I. Sarosi, C. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. Tan, Wei-wei Xu, D. Lacey, W. Boyle, W. Simonet (1998)
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.Genes & development, 12 9
-
Y. Teng, Hai Nguyen, Xuijuan Gao, Y. Kong, R. Gorczynski, Bhagirath Singh, R. Ellen, J. Penninger (2000)
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.The Journal of clinical investigation, 106 6
-
F. Parhami, L. Demer (1997)
Arterial calcification in face of osteoporosis in ageing: can we blame oxidized lipids?Current Opinion in Lipidology, 8
-
M. Lomaga, W. Yeh, I. Sarosi, G. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, Gwyneth Van, S. Kaufman, Annette Heiden, A. Itié, A. Wakeham, W. Khoo, Takehiko Sasaki, Z. Cao, J. Penninger, C. Paige, D. Lacey, C. Dunstan, W. Boyle, D. Goeddel, T. Mak (1999)
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.Genes & development, 13 8
-
W. Simonet, D. Lacey, C. Dunstan, M. Kelley, Ming-Shi Chang, R. Lüthy, Hung Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H. Tan, Geraldine Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, W. Boyle (1997)
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 89
-
M. Bachmann, B. Wong, R. Josien, R. Steinman, A. Oxenius, Yongwon Choi (1999)
TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell ActivationThe Journal of Experimental Medicine, 189
-
R. Mebius, P. Rennert, I. Weissman (1997)
Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells.Immunity, 7 4
-
G. Robinson, Lothar Hennighausen, Peter Johnson (2000)
Side-branching in the mammary gland: the progesterone-Wnt connection.Genes & development, 14 8
-
H. Takayanagi, K. Ogasawara, S. Hida, T. Chiba, S. Murata, Kojiro Sato, A. Takaoka, T. Yokochi, H. Oda, Keiji Tanaka, Kozo Nakamura, T. Taniguchi (2000)
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γNature, 408
-
G. Franzoso, L. Carlson, L. Xing, L. Poljak, E. Shores, K. Brown, A. Leonardi, T. Tran, B. Boyce, U. Siebenlist (1997)
Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 11
-
Jianchao Xu, T. Foy, J. Laman, E. Elliott, J. Dunn, T. Waldschmidt, Jennifer Elsemore, R. Noelle, R. Flavell (1994)
Mice deficient for the CD40 ligand.Immunity, 1 5
-
C. Kovacs, H. Kronenberg (1997)
Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation.Endocrine reviews, 18 6
-
J. Arron, Yongwon Choi (2000)
Osteoimmunology: Bone versus immune systemNature, 408
-
F. Mach, U. Schönbeck, G. Sukhova, Elizabeth Atkinson, P. Libby (1998)
Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 394
-
B. Wong, R. Josien, Soo Lee, B. Sauter, Hong‐li Li, R. Steinman, Yongwon Choi (1997)
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival FactorThe Journal of Experimental Medicine, 186
-
P. Bouillet, D. Metcalf, D. Huang, D. Tarlinton, T. Kay, Frank Koentgen, J. Adams, A. Strasser (1999)
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.Science, 286 5445
-
L. Hofbauer, S. Khosla, C. Dunstan, D. Lacey, T. Spelsberg, B. Riggs (1999)
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.Endocrinology, 140 9
-
L. Hofbauer, D. Lacey, C. Dunstan, T. Spelsberg, B. Riggs, S. Khosla (1999)
Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsBone, 25
-
Jian Zhang, Jinlu Dai, Yinghua Qi, D. Lin, Peter Smith, C. Strayhorn, A. Mizokami, Z. Fu, John Westman, E. Keller (2001)
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.The Journal of clinical investigation, 107 10
-
N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, H. Yasuda, K. Yano, T. Morinaga, K. Higashio (1998)
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.Biochemical and biophysical research communications, 253 2
-
P. Ebeling, B. Erbas, J. Hopper, J. Wark, A. Rubinfeld (1998)
Bone Mineral Density and Bone Turnover in Asthmatics Treated with Long‐Term Inhaled or Oral GlucocorticoidsJournal of Bone and Mineral Research, 13
-
I. Grewal, R. Flavell (1998)
CD40 and CD154 in cell-mediated immunity.Annual review of immunology, 16
-
Y. Kong, H. Yoshida, I. Sarosi, H. Tan, E. Timms, C. Capparelli, S. Morony, A. Oliveira-dos-Santos, G. Van, A. Itié, W. Khoo, A. Wakeham, C. Dunstan, D. Lacey, T. Mak, W. Boyle, J. Penninger (1999)
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesisNature, 397
-
D. Lacey, E. Timms, H. Tan, M. Kelley, C. Dunstan, Tim Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, Charles Capparelli, A. Eli, Y. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, Jane Guo, J. Delaney, W. Boyle (1998)
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 93
-
H. Yasuda, N. Shima, N. Nakagawa, S. Mochizuki, K. Yano, N. Fujise, Yasushi Sato, M. Goto, K. Yamaguchi, M. Kuriyama, Takeshi Kanno, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio (1998)
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.Endocrinology, 139 3
-
Virginia Rider, Nabih Abdou (2001)
Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus.International immunopharmacology, 1 6
-
T. Yun, Preethello Chaudhary, G. Shu, J. Frazer, Maria Ewings, Stephen Schwartz, Virginia Pascual, Leroy Hood, Edward Clark (1998)
OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40.Journal of immunology, 161 11
-
Yangbo Fu, D. Chaplin (1999)
Development and maturation of secondary lymphoid tissues.Annual review of immunology, 17
-
小林 幹一郎 (2002)
Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction -
M. Seitz, W. Hunstein (1985)
Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus.Annals of the Rheumatic Diseases, 44
-
S. Ahmed, D. Hissong, K. Verthelyi, K. Donner, E. Becker, Karpuzoglu-Sahin, Fork Rd, Labs, Virginia-Maryland, S. Ansar, Ahmed (1999)
Gender and risk of autoimmune diseases: possible role of estrogenic compounds.Environmental Health Perspectives, 107
-
D. Wallach (1996)
Suicide by order: some open questions about the cell-killing activities of the TNF ligand and receptor families.Cytokine & growth factor reviews, 7 3
-
H. Brändström, K. Jonsson, O. Vidal, S. Ljunghall, C. Ohlsson, Ö. Ljunggren (1998)
Tumor Necrosis Factor-α and -β Upregulate the Levels of Osteoprotegerin mRNA in Human Osteosarcoma MG-63 CellsBiochemical and Biophysical Research Communications, 248
-
Cathrin Brisken, Sarabjeet Kaur, Tony Chavarria, Nadine Binart, Robert Sutherland, Robert Weinberg, Paul Kelly, C. Ormandy (1999)
Prolactin controls mammary gland development via direct and indirect mechanisms.Developmental biology, 210 1
-
Oliveri Mb, Mautalen Ca, Rodríguez Ca, Romanelli Mc (1991)
Vertebral compression fractures at the onset of acute lymphoblastic leukemia in a child.Henry Ford Hospital medical journal, 39
- Publisher
- Annual Reviews
- Copyright
- Copyright © 2002 by Annual Reviews. All rights reserved
- Subject
- Review Articles
- ISSN
- 0732-0582
- eISSN
- 1545-3278
- DOI
- 10.1146/annurev.immunol.20.100301.064753
- pmid
- 11861618
- Publisher site
- See Article on Publisher Site
Abstract
▪ Abstract TNF and TNFR family proteins play important roles in the control of cell death, proliferation, autoimmunity, the function of immune cells, or the organogenesis of lymphoid organs. Recently, novel members of this large family have been identified that have critical functions in immunity and that couple lymphoid cells with other organ systems such as bone morphogenesis and mammary gland formation in pregnancy. The TNF-family molecule RANK-L (RANK-L, TRANCE, ODF) and its receptor RANK are key regulators of bone remodeling, and they are essential for the development and activation of osteoclasts. Intriguingly, RANK-L/RANK interactions also regulate T cell/dendritic cell communications, dendritic cell survival, and lymph node formation; T cell–derived RANK-L can mediate bone loss in arthritis and periodontal disease. Moreover, RANK-L and RANK are expressed in mammary gland epithelial cells, and they control the development of a lactating mammary gland during pregnancy and the propagation of mammalian species. Modulation of these systems provides us with a unique opportunity to design novel therapeutics to inhibit bone loss in arthritis, periodontal disease, and osteoporosis.
Journal
Annual Review of Immunology – Annual Reviews
Published: Apr 1, 2002